Position in GERN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$128,454
New position
Shares Held
100,355
first reported quarter
Ownership
0.016%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#123
of 258 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 44%
Shared 0%
None 56%
Position in Biotechnology
Healthcare · as of Jun 30, 2026GLOBEFLEX CAPITAL L P holds $30,619,322 across 13 Biotechnology names. GERN ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
254,993 | $13,874,169 | |
| 2 | RIGL |
Rigel Pharmaceuticals Inc
|
112,672 | $4,407,728 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
382,807 | $3,104,564 | |
| 4 | ZVRA |
Zevra Therapeutics, Inc.
|
191,904 | $2,751,903 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
10,645 | $2,565,125 | |
| 6 | AGEN |
Agenus Inc
|
418,581 | $1,280,857 | |
| 7 | INCY |
Incyte Corp
|
8,654 | $981,017 | |
| 8 | ARVN |
Arvinas, Inc.
|
59,331 | $493,040 |
All Filings in GERN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $128,454 | 100,355 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||